Concepedia

Hongjun Zhang

HZ

18

Publications

653

Citations

15

H-Index

2001

Active since

Affiliations

Merck & Co., Inc., Rahway, NJ, USA (United States)(Current)

Quantitative BioSciences

University of Arizona

Tsinghua University

United States Military Academy

Hongjun Zhang is an author at Merck & Co., Inc., Rahway, NJ, USA (United States) specializing in natural sciences, biochemistry, and medicine.

ORCID

Top concepts

Publications per year

2001–2022

18

Publications

18

Identification of an allosteric binding site for RORγt inhibition

Marcel Scheepstra, S. Leysen, Geert C. van Almen et al. · Nature Communications · 2015 · 100 citations · Full text

Discovery of Potent and Orally Available Bicyclo[1.1.1]pentane-Derived Indoleamine-2,3-dioxygenase 1 (IDO1) Inhibitors

Qinglin Pu, Hongjun Zhang, Liangqin Guo et al. · ACS Medicinal Chemistry Letters · 2020 · 82 citations · Full text

A rapid method for detecting conformational changes during differentiation and apoptosis of HL60 cells by Fourier‐transform infrared spectroscopy

Jiangbing Zhou, Zhao Wang, Suqing Sun et al. · Biotechnology and Applied Biochemistry · 2001 · 72 citations

Inhibition of RORγT Skews TCRα Gene Rearrangement and Limits T Cell Repertoire Diversity

Yanxia Guo, Kenzie D. MacIsaac, Yi Chen et al. · Cell Reports · 2016 · 58 citations · Full text

Discovery of Amino-cyclobutarene-derived Indoleamine-2,3-dioxygenase 1 (IDO1) Inhibitors for Cancer Immunotherapy

Hongjun Zhang, K. Liu, Qinglin Pu et al. · ACS Medicinal Chemistry Letters · 2019 · 44 citations · Full text

Rows per page

1–5 of 18